Reviews published in 2025 describe a body of research dominated by animal and cell studies, with signals suggesting effects on angiogenesis (the growth of blood vessels), growth-factor signalling (mainly growth hormone) and musculoskeletal healing
For further research, Leigh, a writer and contributor to GeneFood, also wrote an excellent blog post recently about the genetics of nutrient absorption which is worth a read
Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase
Tirzepatide (Mounjaro / Zepbound) Dosing Tirzepatide is the weekly dual-hormone injection sold as Mounjaro for type 2 diabetes and Zepbound for obesity
Simultaneously, AOD-9604 inhibits lipogenic enzymes that form new fat, creating a dual mechanism that both increases breakdown and decreases formation of stored fat
Im very satisfied